The Use of Living Cell Cartilage Matrix Grafts in the Management of Hallux Rgidus: A Case Series
Received Date: Nov 01, 2022 / Published Date: Nov 30, 2022
Abstract
Hallux rigidus, a condition defined by loss of motion in the first metatarsophalangeal joint and its subsequent progression to arthrosis, is well-documented in the clinical literature. Novel therapies for the management of this condition, such as living-cell cartilage matrix grafts, however, have not been thoroughly investigated. In this study, the authors present two distinct cases of individuals that refused an arthrodesis, but had cartilage damage requiring more than a cheilectomy. Both individuals at 24 months post-surgery remained asymptomatic, and happy with the outcome of their procedure.
Citation: Adrian Wright J, Julia Tanaka BA, Jacob Breitkopf BS (2022) The Use of Living Cell Cartilage Matrix Grafts in the Management of Hallux Rigidus: A Case Series. Clin Res Foot Ankle, 10: 376.
Copyright: © 2022 Adrian Wright J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Usage
- Total views: 1189
- [From(publication date): 0-2022 - Nov 25, 2024]
- Breakdown by view type
- HTML page views: 997
- PDF downloads: 192
